164 related articles for article (PubMed ID: 33903625)
21. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
Sturgis EM; Zhao C; Zheng R; Wei Q
Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
[TBL] [Abstract][Full Text] [Related]
22. Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.
Świerniak M; Wójcicka A; Czetwertyńska M; Długosińska J; Stachlewska E; Gierlikowski W; Kot A; Górnicka B; Koperski Ł; Bogdańska M; Wiechno W; Jażdżewski K
Clin Cancer Res; 2016 Mar; 22(5):1111-9. PubMed ID: 26490305
[TBL] [Abstract][Full Text] [Related]
23. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
[TBL] [Abstract][Full Text] [Related]
24. Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.
Ji X; Bossé Y; Landi MT; Gui J; Xiao X; Qian D; Joubert P; Lamontagne M; Li Y; Gorlov I; de Biasi M; Han Y; Gorlova O; Hung RJ; Wu X; McKay J; Zong X; Carreras-Torres R; Christiani DC; Caporaso N; Johansson M; Liu G; Bojesen SE; Le Marchand L; Albanes D; Bickeböller H; Aldrich MC; Bush WS; Tardon A; Rennert G; Chen C; Teare MD; Field JK; Kiemeney LA; Lazarus P; Haugen A; Lam S; Schabath MB; Andrew AS; Shen H; Hong YC; Yuan JM; Bertazzi PA; Pesatori AC; Ye Y; Diao N; Su L; Zhang R; Brhane Y; Leighl N; Johansen JS; Mellemgaard A; Saliba W; Haiman C; Wilkens L; Fernandez-Somoano A; Fernandez-Tardon G; van der Heijden EHFM; Kim JH; Dai J; Hu Z; Davies MPA; Marcus MW; Brunnström H; Manjer J; Melander O; Muller DC; Overvad K; Trichopoulou A; Tumino R; Doherty J; Goodman GE; Cox A; Taylor F; Woll P; Brüske I; Manz J; Muley T; Risch A; Rosenberger A; Grankvist K; Johansson M; Shepherd F; Tsao MS; Arnold SM; Haura EB; Bolca C; Holcatova I; Janout V; Kontic M; Lissowska J; Mukeria A; Ognjanovic S; Orlowski TM; Scelo G; Swiatkowska B; Zaridze D; Bakke P; Skaug V; Zienolddiny S; Duell EJ; Butler LM; Koh WP; Gao YT; Houlston R; McLaughlin J; Stevens V; Nickle DC; Obeidat M; Timens W; Zhu B; Song L; Artigas MS; Tobin MD; Wain LV; Gu F; Byun J; Kamal A; Zhu D; Tyndale RF; Wei WQ; Chanock S; Brennan P; Amos CI
Nat Commun; 2018 Aug; 9(1):3221. PubMed ID: 30104567
[TBL] [Abstract][Full Text] [Related]
25. Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis.
Duan S; Luo X; Dong C
Gene; 2013 Dec; 531(2):347-54. PubMed ID: 23994195
[TBL] [Abstract][Full Text] [Related]
26. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.
Cipollini M; Figlioli G; Maccari G; Garritano S; De Santi C; Melaiu O; Barone E; Bambi F; Ermini S; Pellegrini G; Cristaudo A; Foddis R; Bonotti A; Romei C; Vivaldi A; Agate L; Molinari E; Barale R; Forsti A; Hemminki K; Elisei R; Gemignani F; Landi S
DNA Repair (Amst); 2016 May; 41():27-31. PubMed ID: 27062014
[TBL] [Abstract][Full Text] [Related]
28. Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
Corrado A; Aceto R; Silvestri R; Dell'Anno I; Ricci B; Miglietta S; Romei C; Giovannoni R; Poliseno L; Evangelista M; Vitiello M; Cipollini M; Garritano S; Giusti L; Zallocco L; Elisei R; Landi S; Gemignani F
Thyroid; 2021 Jul; 31(7):1056-1066. PubMed ID: 33308024
[No Abstract] [Full Text] [Related]
29. Role of DNA Repair Variants and Diagnostic Radiology Exams in Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.
Zidane M; Truong T; Lesueur F; Xhaard C; Cordina-Duverger E; Boland A; Blanché H; Ory C; Chevillard S; Deleuze JF; Souchard V; Ren Y; Zemmache MZ; Canale S; Borson-Chazot F; Schvartz C; Mariné Barjoan E; Guizard AV; Laurent-Puig P; Mulot C; Guibon J; Karimi M; Schlumberger M; Adjadj E; Rubino C; Guenel P; Cazier JB; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1208-1217. PubMed ID: 33827984
[TBL] [Abstract][Full Text] [Related]
30. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
31. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
[TBL] [Abstract][Full Text] [Related]
32. Pathway analysis supports association of nonsyndromic cryptorchidism with genetic loci linked to cytoskeleton-dependent functions.
Barthold JS; Wang Y; Kolon TF; Kollin C; Nordenskjöld A; Olivant Fisher A; Figueroa TE; BaniHani AH; Hagerty JA; Gonzaléz R; Noh PH; Chiavacci RM; Harden KR; Abrams DJ; Kim CE; Li J; Hakonarson H; Devoto M
Hum Reprod; 2015 Oct; 30(10):2439-51. PubMed ID: 26209787
[TBL] [Abstract][Full Text] [Related]
33. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer.
Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N
Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553
[TBL] [Abstract][Full Text] [Related]
34. Genome-Wide Association Study Reveals Distinct Genetic Susceptibility of Thyroid Nodules From Thyroid Cancer.
Hwangbo Y; Lee EK; Son HY; Im SW; Kwak SJ; Yoon JW; Kim MJ; Kim J; Choi HS; Ryu CH; Lee YJ; Kim JI; Cho NH; Park YJ
J Clin Endocrinol Metab; 2018 Dec; 103(12):4384-4394. PubMed ID: 30099483
[TBL] [Abstract][Full Text] [Related]
35. Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology.
Farashi S; Kryza T; Batra J
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32397189
[TBL] [Abstract][Full Text] [Related]
36. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
[TBL] [Abstract][Full Text] [Related]
37. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
38. A variant on chromosome 2p13.3 is associated with atopic dermatitis in Chinese Han population.
Cai XY; Zheng XD; Fang L; Zhou FS; Sheng YJ; Wu YY; Yu CX; Zhu J; Xiao FL
Gene; 2017 Sep; 628():281-285. PubMed ID: 28739399
[TBL] [Abstract][Full Text] [Related]
39. Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Masson G; He H; Jonasdottir A; Sigurdsson A; Stacey SN; Johannsdottir H; Helgadottir HT; Li W; Nagy R; Ringel MD; Kloos RT; de Visser MC; Plantinga TS; den Heijer M; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Walters GB; Bjarnason H; Tryggvadottir L; Eyjolfsson GI; Bjornsdottir US; Holm H; Olafsson I; Kristjansson K; Kristvinsson H; Magnusson OT; Thorleifsson G; Gulcher JR; Kong A; Kiemeney LA; Jonsson T; Hjartarson H; Mayordomo JI; Netea-Maier RT; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Genet; 2012 Jan; 44(3):319-22. PubMed ID: 22267200
[TBL] [Abstract][Full Text] [Related]
40. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
